CF PharmTech, Inc. (HKG:2652)
Hong Kong · Delayed Price · Currency is HKD 6.06
+0.31 (5.30%)
Oct 9, 2026, 4:08 PM HKT
CF PharmTech Market Cap
CF PharmTech has a market cap or net worth of 2.46 billion as of October 9, 2026. It is the 18,124th most valuable company in the world and the 798th biggest in Hong Kong. Its market cap has decreased by 84.49% in one year.
Market Cap
2.46B
Enterprise Value
2.13B
Revenue
504.27M
Global Rank
Country Rank
#798 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since October 8, 2025, CF PharmTech's market cap has decreased from 15.86B to 2.46B, a decrease of -84.49%. That is a compound annual growth rate of -84.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.46B | -82.93% |
| Dec 31, 2025 | 14.42B | -9.11% |
| Oct 8, 2025 | 15.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xuanzhu Biopharmaceutical | 4.27B |
| Edding Genor Group Holdings | 3.36B |
| Hua Medicine (Shanghai) | 2.31B |
| VISEN Pharmaceuticals | 2.06B |
| CPBIO Holding Company | 2.01B |
| Jacobson Pharma Corporation | 1.92B |
| Dawnrays Pharmaceutical (Holdings) | 1.45B |
| Golden Throat Holdings Group Company | 1.42B |